全文获取类型
收费全文 | 3814篇 |
免费 | 255篇 |
国内免费 | 131篇 |
专业分类
4200篇 |
出版年
2024年 | 8篇 |
2023年 | 69篇 |
2022年 | 104篇 |
2021年 | 144篇 |
2020年 | 121篇 |
2019年 | 189篇 |
2018年 | 117篇 |
2017年 | 142篇 |
2016年 | 144篇 |
2015年 | 208篇 |
2014年 | 342篇 |
2013年 | 362篇 |
2012年 | 148篇 |
2011年 | 175篇 |
2010年 | 112篇 |
2009年 | 149篇 |
2008年 | 181篇 |
2007年 | 175篇 |
2006年 | 163篇 |
2005年 | 143篇 |
2004年 | 126篇 |
2003年 | 111篇 |
2002年 | 89篇 |
2001年 | 64篇 |
2000年 | 50篇 |
1999年 | 55篇 |
1998年 | 57篇 |
1997年 | 43篇 |
1996年 | 27篇 |
1995年 | 33篇 |
1994年 | 38篇 |
1993年 | 26篇 |
1992年 | 21篇 |
1991年 | 33篇 |
1990年 | 28篇 |
1989年 | 25篇 |
1988年 | 25篇 |
1987年 | 22篇 |
1986年 | 15篇 |
1985年 | 17篇 |
1984年 | 17篇 |
1983年 | 17篇 |
1982年 | 21篇 |
1981年 | 13篇 |
1980年 | 11篇 |
1979年 | 8篇 |
1978年 | 5篇 |
1974年 | 3篇 |
1973年 | 2篇 |
1970年 | 1篇 |
排序方式: 共有4200条查询结果,搜索用时 15 毫秒
991.
Current treatments for damaged articular cartilage (i.e., shaving the articular surface, perforation or abrasion of the subchondral
bone, and resurfacing with periosteal and perichondrial resurfacing) often produce fibrocartilage, or hyaline-appearing repair
that is not sustained over time (Henche 1967, Ligament and Articular Cartilage Injuries. Springer-Verlag, New York, NY, pp.
157–164; Insall 1974, Clin. Orthop. 101: 61–67; Mitchell and Shepard 1976, J. Bone Joint Surg. [Am.] 58: 230–233; O’Driscoll
et al. 1986, J. Bone Joint Surg. [Am.] 68: 1017–1035; 1989, Trans. Orthop. Res. Soc. 14: 145; Kim et al. 1991, J. Bone Joint
Surg. [Am.] 73: 1301–1315). Autologous chondrocyte transplantation, although promising, requires two surgeries, has site-dependent
and patient age limitations, and has unknown long-term donor site morbidity (Brittberg et al. 1994, N Engl. J. Med. 331: 889–895;
Minas 2003, Orthopedics 26: 945–947; Peterson et al. 2003, J. Bone Joint Surg. Am. 85-A(Suppl. 2): S17–S24). Osteochondral
allografts remain a widely used method of articular resurfacing to delay arthritic progression. The present study compared
the histological response to four types of osteochondral implants in a rabbit model: autograft, frozen, freeze-dried, and
fresh implants. Specimens implanted in the femoral groove were harvested at 6 and 12 weeks. Results showed similar restoration
of the joint surface regardless of implant type, with a trend toward better repair at the later timepoint. As has been observed
in other studies (Frenkel et al. 1997, J. Bone Joint Surg. 79B: 281–286; Toolan et al. 1998, J. Biomed. Mater. Res. 41: 244–250),
each group in this study had at least one specimen in which a healthy-appearing surface on the implant was not well-integrated
with host tissues. Although the differences were not statistically significant, freeze-dried implants at both timepoints had
the best histological scores. The osteochondral grafts tested successfully restored the gross joint surface and congruity.
At 12 weeks, no significant differences were observed between the various allografts and autologous osteochondral grafts. 相似文献
992.
993.
994.
995.
996.
997.
Roberta Bergero Peter Ellis Wilfried Haerty Lee Larcombe Iain Macaulay Tarang Mehta Mette Mogensen David Murray Will Nash Matthew J. Neale Rebecca O'Connor Christian Ottolini Ned Peel Luke Ramsey Ben Skinner Alexander Suh Michael Summers Yu Sun Alison Tidy Raheleh Rahbari Claudia Rathje Simone Immler 《Biological reviews of the Cambridge Philosophical Society》2021,96(3):822-841
The separation of germ cell populations from the soma is part of the evolutionary transition to multicellularity. Only genetic information present in the germ cells will be inherited by future generations, and any molecular processes affecting the germline genome are therefore likely to be passed on. Despite its prevalence across taxonomic kingdoms, we are only starting to understand details of the underlying micro-evolutionary processes occurring at the germline genome level. These include segregation, recombination, mutation and selection and can occur at any stage during germline differentiation and mitotic germline proliferation to meiosis and post-meiotic gamete maturation. Selection acting on germ cells at any stage from the diploid germ cell to the haploid gametes may cause significant deviations from Mendelian inheritance and may be more widespread than previously assumed. The mechanisms that affect and potentially alter the genomic sequence and allele frequencies in the germline are pivotal to our understanding of heritability. With the rise of new sequencing technologies, we are now able to address some of these unanswered questions. In this review, we comment on the most recent developments in this field and identify current gaps in our knowledge. 相似文献
998.
999.
1000.
M Venere P Hamerlik Q Wu R D Rasmussen L A Song A Vasanji N Tenley W A Flavahan A B Hjelmeland J Bartek J N Rich 《Cell death and differentiation》2014,21(2):258-269
Glioblastoma-initiating cells (GICs) are self-renewing tumorigenic sub-populations, contributing to therapeutic resistance via decreased sensitivity to ionizing radiation (IR). GIC survival following IR is attributed to an augmented response to genotoxic stress. We now report that GICs are primed to handle additional stress due to basal activation of single-strand break repair (SSBR), the main DNA damage response pathway activated by reactive oxygen species (ROS), compared with non-GICs. ROS levels were higher in GICs and likely contributed to the oxidative base damage and single-strand DNA breaks found elevated in GICs. To tolerate constitutive DNA damage, GICs exhibited a reliance on the key SSBR mediator, poly-ADP-ribose polymerase (PARP), with decreased viability seen upon small molecule inhibition to PARP. PARP inhibition (PARPi) sensitized GICs to radiation and inhibited growth, self-renewal, and DNA damage repair. In vivo treatment with PARPi and radiotherapy attenuated radiation-induced enrichment of GICs and inhibited the central cancer stem cell phenotype of tumor initiation. These results indicate that elevated PARP activation within GICs permits exploitation of this dependence, potently augmenting therapeutic efficacy of IR against GICs. In addition, our results support further development of clinical trials with PARPi and radiation in glioblastoma. 相似文献